JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8680 MLN0905

Target: PLK

Summary: Potent PLK1 inhibitor

≥24.35 mg/mL
A8687 VX-702
3 Citation

Summary: P38α MAPK inhibitor,highly selective and ATP-competitive

insoluble in H2O; ≥20.2 mg/mL
B1383 VE-822
7 Citation

Target: ATM/ATR

Summary: ATR inhibitor

≥50 mg/mL
B3252 Dorsomorphin (Compound C)
40 Citation

Target: AMPK

Summary: AMPK inhibitor

insoluble in H2O; insoluble in EtOH; ≥8.49 mg/mL
B3275 TCS JNK 5a

Target: JNK

Summary: JNK2 and JNK3 inhibitor

≥16.6 mg/mL
B1584 NVP-ADW742

Summary: Selective IGF-1R inhibitor

Soluble in DMSO
B2284 Fostamatinib (R788)
1 Citation

Target: Syk

Summary: Spleen tyrosine kinase (Syk) inhibitor

insoluble in H2O; ≥100.4 mg/mL
B1426 Org 27569

Target: CB1 Receptors

Summary: Cannabinoid CB1 receptor allosteric modulator

insoluble in H2O; ≥13.95 mg/mL
B1536 AZD1080
1 Citation

Target: GSK-3

Summary: GSK3βinhibitor

insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL
B1628 MPEP

Summary: MGlu5 receptor antagonist

insoluble in H2O; ≥9.95 mg/mL